Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Consolidated Net Income: 2017-2025

Historic Consolidated Net Income for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to -$79.1 million.

  • Autolus Therapeutics' Consolidated Net Income rose 3.63% to -$79.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224.8 million, marking a year-over-year increase of 16.81%. This contributed to the annual value of -$220.7 million for FY2024, which is 5.89% down from last year.
  • Latest data reveals that Autolus Therapeutics reported Consolidated Net Income of -$79.1 million as of Q3 2025, which was down 65.11% from -$47.9 million recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Consolidated Net Income high stood at -$6.8 million for Q4 2021, and its period low was -$44.8 billion during Q3 2021.
  • For the 3-year period, Autolus Therapeutics' Consolidated Net Income averaged around -$56.9 million, with its median value being -$52.7 million (2024).
  • In the last 5 years, Autolus Therapeutics' Consolidated Net Income crashed by 84,283.07% in 2021 and then spiked by 99.90% in 2022.
  • Quarterly analysis of 5 years shows Autolus Therapeutics' Consolidated Net Income stood at -$6.8 million in 2021, then tumbled by 298.16% to -$27.0 million in 2022, then crashed by 186.04% to -$77.2 million in 2023, then surged by 64.23% to -$27.6 million in 2024, then rose by 3.63% to -$79.1 million in 2025.
  • Its Consolidated Net Income was -$79.1 million in Q3 2025, compared to -$47.9 million in Q2 2025 and -$70.2 million in Q1 2025.